Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN & C3G
  - Search for:
- Neurology
  - BACK
  - Neurology
  - Alzheimer's Disease
  - Epilepsy
  - Insomnia
  - Migraine
  - Multiple Sclerosis
  - Tuberous Sclerosis Complex
  - Search for:
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Conference Calendar
Expert Directory
About Expert Perspectives
Login/Register
Search for:

Oncology

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Advertisment

Prospects for Improving Outcomes in High-Risk Diffuse Large B-Cell Lymphoma

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Prospects for Improving Outcomes in High-Risk Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

$Newer Options for Durable Disease Control in Relapsed/Refractory Diffuse Large B-Cell Lymphoma$

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Newer Options for Durable Disease Control in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

$Therapeutic Sequencing in Relapsed/Refractory Diffuse Large B-Cell Lymphoma$

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Therapeutic Sequencing in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

Investigational and Emerging Therapies for Diffuse Large B-Cell Lymphoma

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Investigational and Emerging Therapies for Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

$Double-Hit Relapsed/Refractory Diffuse Large B-Cell Lymphoma$

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Double-Hit Relapsed/Refractory Diffuse Large B-Cell Lymphoma

clinical topic updates
By Matthew J. Matasar, MD

Load More

Experts in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

+0

Meet the Experts

Advertisment

2024 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

By submitting a new user registration you’re agreeing to the Privacy Policy and Terms of Service for Expert Perspectives in Medicine and its subsidiaries.